These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16310767)

  • 1. Treatment with PARP-1 inhibitors, GPI 15427 or GPI 16539, ameliorates intestinal damage in rat models of colitis and shock.
    Di Paola R; Mazzon E; Xu W; Genovese T; Ferrraris D; Muià C; Crisafulli C; Zhang J; Cuzzocrea S
    Eur J Pharmacol; 2005 Dec; 527(1-3):163-71. PubMed ID: 16310767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of 5-aminoisoquinolinone, a novel, potent, water-soluble, inhibitor of poly (ADP-ribose) polymerase, in a rat model of splanchnic artery occlusion and reperfusion.
    Di Paola R; Genovese T; Caputi AP; Threadgill M; Thiemermann C; Cuzzocrea S
    Eur J Pharmacol; 2004 May; 492(2-3):203-10. PubMed ID: 15178366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.
    Cuzzocrea S; Zingarelli B; Costantino G; Szabó A; Salzman AL; Caputi AP; Szabó C
    Br J Pharmacol; 1997 Jul; 121(6):1065-74. PubMed ID: 9249240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP inhibition reduces acute colonic inflammation in rats.
    Sánchez-Fidalgo S; Villegas I; Martín A; Sánchez-Hidalgo M; Alarcón de la Lastra C
    Eur J Pharmacol; 2007 Jun; 563(1-3):216-23. PubMed ID: 17374531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion.
    Cuzzocrea S; Di Paola R; Mazzon E; Cortes U; Genovese T; Muià C; Li W; Xu W; Li JH; Zhang J; Wang ZQ
    FASEB J; 2005 Apr; 19(6):558-66. PubMed ID: 15791006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoproteins reduce the intestinal damage associated with ischemia/reperfusion and colitis.
    Cuzzocrea S; Dugo L; Patel NS; Di Paola R; Cockerill GW; Genovese T; Thiemermann C
    Shock; 2004 Apr; 21(4):342-51. PubMed ID: 15179135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head and neck cancer radiosensitization by the novel poly(ADP-ribose) polymerase inhibitor GPI-15427.
    Khan K; Araki K; Wang D; Li G; Li X; Zhang J; Xu W; Hoover RK; Lauter S; O'Malley B; Lapidus RG; Li D
    Head Neck; 2010 Mar; 32(3):381-91. PubMed ID: 19672867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide treatment reduces colon injury induced by experimental colitis.
    Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
    Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis.
    Di Paola R; Esposito E; Mazzon E; Riccardi L; Caminiti R; Dal Toso R; Pressi G; Cuzzocrea S
    Biochem Pharmacol; 2009 Mar; 77(5):845-57. PubMed ID: 19070602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPI 6150 prevents H(2)O(2) cytotoxicity by inhibiting poly(ADP-ribose) polymerase.
    Zhang J; Lautar S; Huang S; Ramsey C; Cheung A; Li JH
    Biochem Biophys Res Commun; 2000 Nov; 278(3):590-8. PubMed ID: 11095954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat.
    Mazzon E; Dugo L; Li JH; Di Paola R; Genovese T; Caputi AP; Zhang J; Cuzzocrea S
    Biochem Pharmacol; 2002 Jul; 64(2):327-37. PubMed ID: 12123754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Aminoisoquinolin-1(2H)-one, a water-soluble poly (ADP-ribose) polymerase (PARP) inhibitor reduces the evolution of experimental periodontitis in rats.
    Di Paola R; Mazzon E; Muià C; Terrana D; Greco S; Britti D; Santori D; Oteri G; Cordasco G; Cuzzocrea S
    J Clin Periodontol; 2007 Feb; 34(2):95-102. PubMed ID: 17309584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of GPI 6150, an inhibitor of poly(ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion.
    Mazzon E; Dugo L; De SA; Li JH; Caputi AP; Zhang J; Cuzzocrea S
    Shock; 2002 Mar; 17(3):222-7. PubMed ID: 11900342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
    Eltze T; Boer R; Wagner T; Weinbrenner S; McDonald MC; Thiemermann C; Bürkle A; Klein T
    Mol Pharmacol; 2008 Dec; 74(6):1587-98. PubMed ID: 18809672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
    Drel VR; Xu W; Zhang J; Kador PF; Ali TK; Shin J; Julius U; Slusher B; El-Remessy AB; Obrosova IG
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection from DNBS-induced colitis by the tachykinin NK(1) receptor antagonist SR140333 in rats.
    Ursino MG; Vasina V; De Ponti F
    Eur J Pharmacol; 2009 Jan; 603(1-3):133-7. PubMed ID: 19103194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock.
    Cuzzocrea S; Di Paola R; Mazzon E; Genovese T; Muià C; Caputi AP
    Shock; 2004 Oct; 22(4):340-6. PubMed ID: 15377889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein.
    Mazzon E; Genovese T; Di Paola R; Muià C; Crisafulli C; Malleo G; Esposito E; Meli R; Sessa E; Cuzzocrea S
    Eur J Pharmacol; 2006 Nov; 549(1-3):149-56. PubMed ID: 16979620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma.
    Tentori L; Leonetti C; Scarsella M; Muzi A; Mazzon E; Vergati M; Forini O; Lapidus R; Xu W; Dorio AS; Zhang J; Cuzzocrea S; Graziani G
    FASEB J; 2006 Aug; 20(10):1709-11. PubMed ID: 16809434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-Ribose) polymerase inhibition improves endothelial dysfunction induced by hypochlorite.
    Radovits T; Zotkina J; Lin LN; Bömicke T; Arif R; Gerö D; Horváth EM; Karck M; Szabó C; Szabó G
    Exp Biol Med (Maywood); 2007 Oct; 232(9):1204-12. PubMed ID: 17895528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.